Dr. Pierre Kory M.P.A., M.D
Pulmonary and Critical Care Specialist, Master Educator, Clinical Researcher. Founding member of the Front-Line COVID-19 Critical Care Alliance ( FLCCC) and co-author of the I-MASK+, MATH+, and I-RECOVER treatment protocols. Dr. Kory is Board Certified in Internal Medicine, Pulmonary Diseases, and Critical Care Medicine, he was previously an Associate Professor and Chief of Critical Care Service, and Medical Director of Trauma and Life Support Center at the University of Wisconsin.
Board Certified in Internal Medicine, Pulmonary Diseases, and Critical Care Medicine
Former Associate Professor, Chief of Critical Care Service, and Medical Director of Trauma and Life Support Center at the University of Wisconsin
President and Chief Medical Officer of the Front Line COVID-19 Critical Care Alliance
Widely published expert on therapeutic approaches to COVID-19
Deeply experienced in treatment of COVID-19 in all its phases – prevention, early, late, long-haul, and post-vaccine syndromes
Pioneer and Senior Editor of a best-selling and award winning textbook, Point of Care Ultrasound
1988–1994 B.A. University of Colorado, Boulder, Colorado Major Mathematics
1994–1996 M.P.A. New York University, New York, NY Health Policy and Administration
1998–2002 M.D. St. George’s University Grenada, West Indies
2002–2005 Residency Internal Medicine, Columbia College of Physicians and Surgeons, New York, NY, St. Luke’s–Roosevelt Hospital, New York
2005–2008 Fellowship Pulmonary Disease and Critical Care Medicine Albert Einstein College of Medicine, Beth Israel Medical Center, New York
2015 Wisconsin Medical License
2015 Illinois Medical License
2009 Healthcare Simulation Training - Instructor Certification
2008, 2019 Pulmonary Diseases
2008, 2018 Critical Care Medicine
2008 National Board Exam in Echocardiography - Pass
2005, 2015 Internal Medicine
Awards & Honors
Awards in the Field of Medicine
My achievements so far for my research and service that improve the lives of people with critical and physical illness.
Dr. Pierre Kory and the Advanced COVID-19 Care Center.
The Center .
Dr. Kory is the founder and lead physician of the Advanced COVID-19 Care Center, a clinic that utilizes remote communication strategies (text, telephone, and video) to conduct illness assessments and develop and prescribe appropriate treatment plans for all phases of COVID-19, including those of the COVID vaccine-injured. He is an internationally renowned and extensively published expert in the prevention and treatment of COVID-19. Dr. Kory has also gained experience through his collaborations with other expert groups in treating those suffering from both “Long Haul COVID” and/or post-COVID-19 vaccine syndromes.
A clinic designed to address people’s individual health needs as they are faced with the challenge of preventing, treating or thriving post-COVID-19 infection or vaccination.
The Provider Team of the Advanced COVID-19 Care Center .
Dr. Kory has trained a team of nurse practitioners and physicians in the use of his protocols. This specialized knowledge allows them to formulate a treatment regimen that best applies to any given patient’s situation. Their treatment protocols include combinations of both FDA-approved and off-label recommended medicines used around the world for all phases and complications of COVID. Each prevention or treatment protocol is created according to each individual patient’s risk factors such as age, co-morbid conditions, severity, co-existing medications, pregnancy status, the phase of illness, and/or suspected variant when presenting. Further, Dr. Kory and his provider team continually adapt the protocols to any rapidly emerging variant and/or trial results of therapeutics by relying on the best and most up-to-date medical evidence along with his daily communications with similar experts in his ever-growing network of committed colleagues around the world.
Dr. Pierre Kory - World-Renowned Expert in the Use of Ivermectin in COVID-19
Value of Ivermectin in Treatment of COVID
Dr. Kory testified in a Senate hearing as long ago as December 2020, that Ivermectin should be systematically deployed as a therapeutic in the prevention and early treatment of COVID worldwide. Since that testimony, 23 countries, (39 when considering non-governmental organizations) have adopted either partial or full use of ivermectin in their guidelines, encompassing 25% of the world’s population. His plea to the U.S government’s medical authorities – the NIH, CDC, and FDA – to urgently review the latest data and then issue guidelines for physicians, nurse practitioners, and physician assistants to prescribe Ivermectin for Covid-19 led to their no longer recommending against use, albeit falling short of a full recommendation for use.
COVID-19 Care Services
Dr. Kory and his team offer specialized evaluation and treatment plans for the multiple phases and complications of COVID-19 illness as below.